Suchergebnisse - (Subject:"PARP inhibitor")

PubPharm (159)

1

Novel dual action PARP and microtubule polymerization inhibitor AMXI-5001 powerfully inhibits growth of esophageal carcinoma both alone and in combination with radiotherapy

enthalten in: American journal of cancer research | 2024

von Brand, N. | Yang, Y. | Ding, V. | +4

2

PARP2 promotes inflammation in psoriasis by modulating estradiol biosynthesis in keratinocytes

enthalten in: Journal of molecular medicine | 2023

von Antal, D. | Pór, �. | Kovács, I. | +9

3

PARP inhibitors and overall survival in ovarian cancer, reevaluation advised in all settings

enthalten in: Journal of cancer research and clinical oncology | 2023

von Olivier, T. | Prasad, V.

4

Adjuvant olaparib in the subset of patients from Japan with BRCA1- or BRCA2-mutated high-risk early breast cancer from the phase 3 OlympiA trial

enthalten in: Breast cancer | 2023

von Yamauchi, H. | Toi, M. | Takayama, S. | +7

5

Synergistic effect of combined PI3 kinase inhibitor and PARP inhibitor treatment on BCR/ABL1-positive acute lymphoblastic leukemia cells

enthalten in: International journal of hematology | 2022

von Hiroki, H. | Akahane, K. | Inukai, T. | +2

6

Veliparib with frontline chemotherapy and as maintenance in Japanese women with ovarian cancer: a subanalysis of efficacy, safety, and antiemetic use in the phase 3 VELIA trial

enthalten in: International journal of clinical oncology | 2022

von Mizuno, M. | Ito, K. | Nakai, H. | +18

7

Pamiparib in patients with locally advanced or metastatic HER2-negative breast cancer with germline BRCA mutations: a phase II study

enthalten in: Breast cancer research and treatment | 2022

von Xu, B. | Sun, T. | Shi, Y. | +22

8

Carbon nanoparticles induce DNA repair and PARP inhibitor resistance associated with nanozyme activity in cancer cells

enthalten in: Cancer nanotechnology | 2022

von Fan, H. | Sun, Q. | Dukenbayev, K. | +10

9

Resistance to Poly (ADP-Ribose) Polymerase Inhibitors (PARPi): Mechanisms and Potential to Reverse

enthalten in: Current oncology reports | 2022

von Washington, C. | Moore, K.

10

Emerging strategies: PARP inhibitors in combination with immune checkpoint blockade in BRCA1 and BRCA2 mutation-associated and triple-negative breast cancer

enthalten in: Breast cancer research and treatment | 2022

von Gupta, T. | Vinayak, S. | Telli, M.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[16]